Results 121 to 130 of about 37,927 (295)
Genetics of calcium homeostasis in humans: continuum between monogenic diseases and continuous phenotypes [PDF]
Extracellular calcium participates in several key physiological functions, such as control of blood coagulation, bone calcification or muscle contraction.
Bochud, M., Bonny, O.
core +1 more source
Primary hypoparathyroidism in a dog
The hypoparathyroidism is a rare endocrinopathy reported in dogs, caused by a deficiency in the synthesis of parathyroid hormone (PTH). The lack of PTH causes hypocalcemia and hyperphosphatemia, resulting in a series of neurological and neuromuscular ...
Mateus do Amaral Freitas +4 more
doaj +1 more source
Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature [PDF]
Background: Differentiated thyroid cancer (DTC) occurs in relatively young patients and is associated with a good prognosis and long survival. The management of this disease involves thyroidectomy, radioiodine therapy, and long-term thyroid-stimulating ...
Balasubramanian, S.P.+2 more
core +2 more sources
Hypocalcemia following total thyroidectomy: early factors predicting long-term outcome [PDF]
Hypocalcemia following total thyroidectomy (TT) must be considered permanent in patients requiring calcium replacement therapy after one year. The aim of this study was to identify early risk factors predicting long-term outcome of postoperative ...
Cois, Alessandro+3 more
core +1 more source
Rare association of Fahr’s disease with multiple myeloma: A case report [PDF]
Fahr’s disease or Fahr’s syndrome is a rare neurological disorder characterized by abnormal calcified deposits in the basal ganglia and cerebral cortex.
GC Misra+3 more
core +1 more source
Hypoparathyroidism and Pseudo-hypoparathyroidism [PDF]
S. H. Llewellyn Smith+2 more
openaire +3 more sources
CONTEXT Conventional treatment of hypoparathyroidism is associated with decreased renal function and increased bone mineral density (BMD). OBJECTIVE To evaluate the effects of 8 years of recombinant human parathyroid hormone (1-84) [rhPTH(1-84 ...
Y. Tay+8 more
semanticscholar +1 more source
Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy.
CONTEXT Calcium and vitamin D treatment does not improve reduced quality of life (QOL) in hypoparathyroidism. Recombinant human (rh) PTH(1-84) therapy improves QOL metrics for up to 5 years.
G. Tabacco+8 more
semanticscholar +1 more source
Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study. [PDF]
There are no consistent data on the prevalence and bone status of normocalcaemic hypoparathyroidism (NHYPO) as defined by normal adjusted calcium and low PTH level.
Bilezikian+35 more
core +1 more source